Dr. Jeffrey Kirshner: Melanoma and Lung Cancer–More Specific, Less Toxic, and More Effective Targeted Therapies
Dr. Jeffrey Kirshner: Melanoma and Lung Cancer–More Specific, Less Toxic, and More Effective Targeted Therapies
Jeffrey Kirshner, MD
20111016
2011 Nov 16
Interview by L Scott Zoeller
Dr. Jeffrey Kirshner: Melanoma and Lung Cancer–More Specific, Less Toxic, and More Effective Targeted Therapies
Interview by L Scott Zoeller. 2011 Nov 16, Jeffrey Kirshner, MD
To mark 2011, we have asked our distinguished OncologySTAT Advisory Board Members to choose their top story of the year. This year, Dr. Jeffrey Kirshner discusses his choices in melanoma and lung cancer. OncologySTAT: In your view, which development in oncology research that occurred in 2011 could have the most significant impact on oncology?Dr. Kirshner: As a practicing clinical oncologist, I believe the most significant development in 2011 was the availability of two new targeted agents, crizotinib...
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
